IBS is a common gastrointestinal disorder affecting the intestine. It affects how contents move through the bowel (motility), and how the brain interprets sensations that occur along the digestive tract (sensitivity), leading to the symptoms below. Although often disruptive, debilitating and embarrassing, IBS is not life-threatening, nor does it lead to cancer or other more serious illnesses.
Book your BioGut JourneyCutting-edge whole-genome sequencing for personalized health insights.
Comprehensive microbiome profiling to understand and improve gut health.
Integrating diverse omic data for a complete health picture.
Specialized tests for specific conditions, providing detailed insights.
Advanced genetic sequencing for precise cancer diagnosis and treatment.
Utilizing the latest technologies for accurate and early disease detection.
BioAro's proactive risk strategy revolutionizes Healthcare with personalized insights. By predicting individual risks, we empower early interventions and informed lifestyle choices, tailored to each unique profile.
Our commitment to innovation and ethical practice underpins ongoing advancements in predictive healthcare.
At the heart of Biospan's approach is a synergy of BioAro's divisions. Our comprehensive care leverages BioTech's cutting-edge devices and BioPhenome's precise diagnostics for unparalleled health optimization
Comprehensive data acquisition strategy from medical consultations, wearable technologies and facial recognition onboarding.
Early disease identification utilizing data from functional biomarkers, comprehensive imaging, and wearables.
Data analysis through advanced and proprietary technology using artificial intelligence and machine learning predictive analytics.
Crafting health plans based on individual DNA, minimizing medication side effects, and tailoring treatments.
BioAro leads in technological innovation with platforms like BioChain and BioEMR. Integrated seamlessly into Biospan services, these technologies represent the pinnacle of precision health and patient-centric care period.
BioAro aims to create innovative and proprietary software solutions to enhance patient care, streamline workflows, and improve the overall efficiency of healthcare practices. To achieve these objectives, BioAro is developing a wide range of software solutions, including BioEMR, PGAro, PanOmic, GMP, and Anryton.
Cutting-edge whole-genome sequencing for personalized health insights.
Comprehensive microbiome profiling to understand and improve gut health.
Integrating diverse omic data for a complete health picture.
Specialized tests for specific conditions, providing detailed insights.
Advanced genetic sequencing for precise cancer diagnosis and treatment.
Utilizing the latest technologies for accurate and early disease detection.
Leveraging AI to forecast health outcomes, enhancing preventive care.
Deep analysis of medical research data, driving innovative health solutions.
Comprehensive analysis across omics data types (genomics, transcriptomics, proteomics, metabolomics) in a unified platform.
Advanced algorithms providing a personalized treatment roadmap based on genetic variations.
AI-powered Electronic Medical Record system revolutionizing healthcare management and practices.
Enhancing health data security, privacy, and interoperability with blockchain technology.
Monitoring genetic changes, identifying emerging health risks, and providing proactive alerts.
Merging genomics with clinical insights for a holistic health perspective. From raw, unstructured data to structured, actionable insights.
At BioAro, we uphold the highest standards of data integrity and ethical practice. Our technology safeguards patient data, ensuring trust and security in every aspect of our healthcare services.
Compliance with global and regional data protection regulations Periods.
Ensuring data is securely encoded and protected from unauthorized access.
Continuous evaluation and strengthening of security protocols Periods.
Commitment to ethical standards in the collection, storage, and use of health data.
Clear communication of data usage and patient rights.
Limiting data access to authorized personnel only.